Hongxin Bio

Hongxin Bio

虹信生物

Hongxin Bio

Biotech/Healthcare

Hongxin Biotech is an mRNA drug developer focused on nucleic acid drug delivery and RNA therapeutics. With deep expertise in nucleic acid delivery, the company has developed a library of ionizable amino lipids with fully independent intellectual property rights.

Latest round: Series B (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-08-13

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.